市場調査レポート

商品コード

1562475

オルソバイオロジクスの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Orthobiologics Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年09月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

オルソバイオロジクスの世界市場規模は、2022年に61億米ドルと評価され、2023年の64億3,000万米ドルから2031年には98億7,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは5.5%で成長する見通しです。

オルソバイオロジクス市場は、いくつかの重要な要因によって、予測期間中に大きな成長が見込まれています。スポーツ傷害と交通事故の頻度の増加は、市場拡大を促進すると予測される2つの顕著な要因です。さらに、脊椎疾患や障害の発生率の増加が市場の成長に寄与すると予測されています。さらに、低侵襲治療に対する患者の嗜好が高まっていることも市場拡大を後押しすると思われるが、オルソバイオロジクスに基づく治療に関連する高コストが市場抑制要因として作用する可能性があります。また、高齢者や肥満人口の増加も市場の追い風となり、需要をさらに加速させています。再生細胞療法としても知られるオルソバイオロジクスは、不快感を和らげるだけでなく、組織の治癒を促進し、正常な機能の回復を助ける成長因子を含む製品で構成されています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic PLC
Stryker Corporation
Globus Medical, Inc.
Orthofix International N.V.
RTI Surgical, Inc.
Kuros Biosciences Ltd.
Bioventus LLC
Nuvasive, Inc.
Seaspine Holdings Corporation
Arthrex, Inc.
Xtant Medical Holdings, Inc.
Smith & Nephew plc
Sanofi S.A.
Integra LifeSciences Holdings Corporation
Anika Therapeutics, Inc.
Alphatec Spine, Inc.
Orthocell Ltd.
MiMedx Group, Inc.
Orthofix Medical Inc.
Bone Therapeutics SA

Product Code: SQMIG35D2070

Global Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The orthobiologics market is expected to experience significant growth during the forecast period, driven by several key factors. The increasing frequency of sports injuries and traffic accidents are two prominent factors anticipated to fuel market expansion. Additionally, the rising incidence of spinal diseases and disorders is projected to contribute to the market's growth. Furthermore, the growing patient preference for minimally invasive procedures is likely to support market expansion, though this may be tempered by the high costs associated with orthobiologics-based treatments, which could act as a restraint. The market is also benefiting from the growing elderly and obese population, which further accelerates demand. Orthobiologics, also known as regenerative cellular therapies, comprise products containing growth factors that not only alleviate discomfort but also promote tissue healing and help restore normal function.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segmental Analysis

Global Orthobiologics Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate. Based on Application, the market is segmented into Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications. Based on End User, the market is segmented into Hospitals, Orthopedic Clinics, & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Orthobiologics Market

Viscosupplements are in high demand and are expected to significantly contribute to the growth of the orthobiologics market. Knee osteoarthritis, a common issue among the elderly, is extensively treated with viscosupplements, which are hyaluronic acid injections administered directly into the joints. The expansion of the viscosupplements segment is driven by factors such as high product costs, the entry of new manufacturers, and recent marketing approvals. Additionally, the segment is benefiting from improved reimbursement policies, further enhancing its growth prospects. Given these factors, the increasing demand for viscosupplements is anticipated to drive the expansion of the global orthobiologics market during the forecast period.

Restraints in the Global Orthobiologics Market

The growing patient preference for minimally invasive procedures is expected to present challenges to the expansion of the orthobiologics market. Additionally, the market may face further difficulties due to the adverse effects associated with BMP-based therapy. Another significant constraint is the surging prices of orthobiologics-based treatments, which may hinder market growth throughout the forecast period. The complex synthesis processes, stringent manufacturing regulations, and high production costs further limit market expansion. Moreover, the high costs associated with orthobiologics products and treatments, coupled with inadequate reimbursement policies, are major obstacles impeding the growth of the global orthobiologics market.

Market Trends of the Global Orthobiologics Market

The global orthobiologics market is expected to grow significantly, driven by the high prevalence of sports-related injuries. For example, a study titled "Results on Sports-Related Injuries in Children from NHS Emergency Care Dataset Oxfordshire Pilot: An Ecological Study," published in November 2018, revealed that 47.4 percent of emergency department visits related to sports injuries involved children aged 0 to 19, and approximately 23.5 percent of all age groups' admissions were due to sports injuries. However, the cost of orthobiologics is variable in the global market. According to a University of Alabama at Birmingham study, as reported in an article published in Sports Health in October 2019, the cost of orthobiologics therapy can range from a few hundred dollars to as much as $12,000. This price fluctuation adds a layer of complexity to the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Supply Chain Analysis
Ecosystem of the Market
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Orthobiologics Market by Product

Market Overview
Viscosupplementation Products
Demineralized Bone Matrices
Synthetic Orthobiologics
Bone Morphogenic Protein
Allografts
Plasma-Rich Protein
Bone Marrow Aspirate Concentrate

Orthobiologics Market by Application

Market Overview
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Soft-Tissue Injuries
Fracture Recovery
Maxillofacial and Dental Applications

Orthobiologics Market by End User

Market Overview
Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
Research & Academic Institutes
Dental Clinics and Facilities

Orthobiologics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Globus Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix International N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuros Biosciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvasive, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seaspine Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xtant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Spine, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthocell Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MiMedx Group, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bone Therapeutics SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

オルソバイオロジクスの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Orthobiologics Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

オルソバイオロジクス市場：製品別

オルソバイオロジクス市場：用途別

オルソバイオロジクス市場：エンドユーザー別

オルソバイオロジクス市場規模：地域別